Skip to main content
Equibles

SYNGENE · Syngene International Limited · Documents

Use SYNGENE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SYNGENE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
444.30 INR -3.50 (-0.78%) At close · Nov 13
Rebalance outlook locked
Market Cap
179.35B INR
Shares
403.67M
Volume · Nov 13 663.8K Avg daily vol (3M) 1.28M

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 28, 2026
2026
Oct 28
Earnings call
Q2 2027 earnings call

Syngene reported second-quarter revenue of 833 crores, up 13% sequentially, operating EBITDA of 147 crores at an 18% margin, and profit after tax of 32 crores. It signed its first Bayview Biologics manufacturing agreement and maintained guidance of mid-20 EBITDAs excluding forex losses.

Showing 1–2 of 2 documents